Reference : Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for th...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/223191
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture.
English
Hiligsmann, M. []
Williams, S.A. []
Fitzpatrick, L.A. []
Silverman, S. []
Weiss, R. []
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Apr-2018
Osteoporosis International
Springer
29 S1
302
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Germany
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
du 19 au 22 avril 2018
WCO-IOF-ESCEO
Cracovie
Pologne
http://hdl.handle.net/2268/223191

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for the prevention of osteoporotic fractures in postmenopausal women at increased risk of fracture..pdfPublisher postprint635.05 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.